KR102693739B1 - 인간 인터류킨 15를 발현하는 면역결핍 마우스 - Google Patents

인간 인터류킨 15를 발현하는 면역결핍 마우스 Download PDF

Info

Publication number
KR102693739B1
KR102693739B1 KR1020207006440A KR20207006440A KR102693739B1 KR 102693739 B1 KR102693739 B1 KR 102693739B1 KR 1020207006440 A KR1020207006440 A KR 1020207006440A KR 20207006440 A KR20207006440 A KR 20207006440A KR 102693739 B1 KR102693739 B1 KR 102693739B1
Authority
KR
South Korea
Prior art keywords
cells
human
mouse
immunodeficient
mice
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020207006440A
Other languages
English (en)
Korean (ko)
Other versions
KR20200135274A (ko
Inventor
레오나드 디. 슐츠
마이클 에이. 브렘
데일 엘. 그라이너
Original Assignee
더 잭슨 래보라토리
유니버시티 오브 매사추세츠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더 잭슨 래보라토리, 유니버시티 오브 매사추세츠 filed Critical 더 잭슨 래보라토리
Publication of KR20200135274A publication Critical patent/KR20200135274A/ko
Application granted granted Critical
Publication of KR102693739B1 publication Critical patent/KR102693739B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5443—IL-15
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/12—Animals modified by administration of exogenous cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A01K2217/052—Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0331—Animal model for proliferative diseases

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
KR1020207006440A 2017-08-09 2018-08-09 인간 인터류킨 15를 발현하는 면역결핍 마우스 Active KR102693739B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762543218P 2017-08-09 2017-08-09
US62/543,218 2017-08-09
US201762554818P 2017-09-06 2017-09-06
US62/554,818 2017-09-06
PCT/US2018/046021 WO2019032836A1 (en) 2017-08-09 2018-08-09 IMMUNODEFICIENT MOUSE EXPRESSING THE HUMAN INTERLEUKINE 15

Publications (2)

Publication Number Publication Date
KR20200135274A KR20200135274A (ko) 2020-12-02
KR102693739B1 true KR102693739B1 (ko) 2024-08-13

Family

ID=63557672

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020207006440A Active KR102693739B1 (ko) 2017-08-09 2018-08-09 인간 인터류킨 15를 발현하는 면역결핍 마우스

Country Status (10)

Country Link
US (1) US20200236916A1 (cg-RX-API-DMAC7.html)
EP (1) EP3664603B1 (cg-RX-API-DMAC7.html)
JP (1) JP7404237B2 (cg-RX-API-DMAC7.html)
KR (1) KR102693739B1 (cg-RX-API-DMAC7.html)
CN (2) CN112118734A (cg-RX-API-DMAC7.html)
AU (1) AU2018313892B2 (cg-RX-API-DMAC7.html)
CA (1) CA3072331A1 (cg-RX-API-DMAC7.html)
IL (1) IL272475B2 (cg-RX-API-DMAC7.html)
SG (1) SG11202001109PA (cg-RX-API-DMAC7.html)
WO (1) WO2019032836A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018102546A1 (en) 2016-11-30 2018-06-07 The Jackson Laboratory Humanized mouse model with improved human innate immune cell development
WO2021150936A1 (en) * 2020-01-22 2021-07-29 City Of Hope Oncolytic virus compositions including il-15 complex and methods for the treatment of cancer
WO2021159035A1 (en) 2020-02-07 2021-08-12 City Of Hope Oncolytic virus compositions and methods for the treatment of cancer
CN111485001A (zh) * 2020-04-14 2020-08-04 澎立生物医药技术(上海)有限公司 具有nk细胞及adcc能力的人源化免疫系统小鼠的构建方法
CN114304065A (zh) * 2021-12-31 2022-04-12 江苏大学 一种阻断il-8联合抗pd-1抗体治疗胃癌的动物模型构建及应用
WO2024029561A1 (ja) * 2022-08-02 2024-02-08 学校法人東海大学 担がん-免疫不全非ヒト動物、これを用いた供試物質に関するがん免疫応答評価方法
AU2023338373A1 (en) * 2022-09-08 2025-04-03 The Jackson Laboratory Humanized immunodeficient mouse models

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016168212A1 (en) 2015-04-13 2016-10-20 Regeneron Pharmaceuticals, Inc. Humanized sirpa-il15 knockin mice and methods of use thereof
WO2016189799A1 (ja) * 2015-05-27 2016-12-01 公益財団法人実験動物中央研究所 ヒトil-15分泌免疫不全マウス
WO2016209865A1 (en) 2015-06-23 2016-12-29 The Jackson Laboratory Non-hla matched humanized nsg mouse model with patient-derived xenograft

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1802193B1 (en) 2004-10-19 2014-04-30 Regeneron Pharmaceuticals, Inc. Method for generating a mouse homozygous for a genetic modification
JP6492095B2 (ja) * 2013-10-15 2019-03-27 リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. ヒト化il−15動物
US20150282460A1 (en) * 2014-04-04 2015-10-08 Crown Bioscience Inc. (Taicang) Animal model with human immune system

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016168212A1 (en) 2015-04-13 2016-10-20 Regeneron Pharmaceuticals, Inc. Humanized sirpa-il15 knockin mice and methods of use thereof
WO2016189799A1 (ja) * 2015-05-27 2016-12-01 公益財団法人実験動物中央研究所 ヒトil-15分泌免疫不全マウス
WO2016209865A1 (en) 2015-06-23 2016-12-29 The Jackson Laboratory Non-hla matched humanized nsg mouse model with patient-derived xenograft

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
Annu Rev Pathol vol.12 pp.187-205(2017)
Blood Vol.119 no.12 pp.2778-2788(2012).
Haematologica vol.100(4) pp.489-498(2015)
Immunology vol.97(1) pp.159-165(1999)
J Clin Invest. vol.129(5) pp.2094-2106(2019)
J Immunol., vol.197(1) pp.78-84(2016)
J Transl Med. vol.9, 113(2011)
Open Immunol J vol.2 pp.79-85(2009)
Rettman, et al., AACR Annual Meeting 2022, Abstract nr 4247, Cancer Res 2022

Also Published As

Publication number Publication date
US20200236916A1 (en) 2020-07-30
AU2018313892B2 (en) 2024-04-18
EP3664603B1 (en) 2024-01-03
CA3072331A1 (en) 2019-02-14
EP3664603A1 (en) 2020-06-17
IL272475A (en) 2020-03-31
JP7404237B2 (ja) 2023-12-25
CN116998459A (zh) 2023-11-07
IL272475B2 (en) 2025-05-01
AU2018313892A1 (en) 2020-02-20
SG11202001109PA (en) 2020-03-30
KR20200135274A (ko) 2020-12-02
IL272475B1 (en) 2025-01-01
WO2019032836A1 (en) 2019-02-14
CN112118734A (zh) 2020-12-22
JP2021500918A (ja) 2021-01-14

Similar Documents

Publication Publication Date Title
US12409237B1 (en) Methods and models for assessing efficacy of immunotherapies
AU2018313892B2 (en) Immunodeficient mice expressing human interleukin 15
CN110868850B (zh) 缺乏i类和ii类mhc的nsg小鼠
EP2618656B1 (en) HUMAN SIRPalpha TRANSGENIC ANIMALS AND THEIR METHODS OF USE
CA2507880A1 (en) Transgenic mice expressing human cd20 and/or cd16
WO2021136537A1 (en) GENETICALLY MODIFIED IMMUNODEFICIENT NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC SIRPα/CD47
US20230227531A1 (en) Genetically modified non-human animal expressing a b2m/fcrn fusion protein
WO2023041035A1 (en) Genetically modified non-human animal with human or chimeric genes
CN108471732A (zh) 与肿瘤分析相关的组合物和方法
US20250255282A1 (en) Vectors, genetically modified cells, and genetically modified non-human animals comprising the same

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20200304

Patent event code: PA01051R01D

Comment text: International Patent Application

N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20201029

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20210804

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20230830

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20240523

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20240806

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20240807

End annual number: 3

Start annual number: 1

PG1601 Publication of registration